Skip to main content
Fig. 1 | Stem Cell Research & Therapy

Fig. 1

From: Topical and intravenous administration of human umbilical cord mesenchymal stem cells in patients with diabetic foot ulcer and peripheral arterial disease: a phase I pilot study with a 3-year follow-up

Fig. 1

Flowchart of the study procedure. a The patients completed a long-term follow-up for 3 years after the last dose of hUC-MSCs and received laboratory tests, ulcer healing assessments, and vascular status monitoring for safety and efficacy evaluations. b Fourteen patients were included in the current study and completed the follow-up assessments

Back to article page

Stem Cell Research & Therapy

ISSN: 1757-6512